Macau, China vs Serbia: Tuberculosis patients living with HIV receiving antiretroviral therapy
Macau, China
3 patients
in 2021
Serbia
3 patients
in 2019
Macau, China rank
117th
Serbia rank
117th
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Macau, China
- Serbia
How they compare
Macau, China currently reports 3 patients against 3 patients in Serbia, a difference of 0 patients.
Across all 15 years both countries report, Serbia has been ahead every year.
Macau, China ranks 117th and Serbia ranks 117th of 183 countries.
Serbia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Macau, China | Serbia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.6 patients | 7.2 patients | 6.6 patients | Serbia |
| 2010s | 1.8 patients | 7.9 patients | 6.1 patients | Serbia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Macau, China or Serbia?
- Macau, China, at 3 patients against 3 patients in Serbia as of 2021.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Macau, China and Serbia?
- 0 patients, with Macau, China ahead.
- How many years of comparable data are there for Macau, China and Serbia?
- 15 years are reported by both, from 2005 to 2019.
- How do Macau, China and Serbia rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Macau, China ranks 117th and Serbia ranks 117th of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.